Diametric Capital’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-512,361
Closed -$1.15M 500
2024
Q2
$1.15M Buy
512,361
+358,883
+234% +$804K 0.62% 35
2024
Q1
$440K Buy
153,478
+84,607
+123% +$243K 0.24% 96
2023
Q4
$122K Sell
68,871
-691,143
-91% -$1.22M 0.07% 221
2023
Q3
$2.4M Buy
+760,014
New +$2.4M 1% 15